Brannin McBee trusts trade 28,000 CoreWeave (CRWV) shares in planned sales
Rhea-AI Filing Summary
CoreWeave, Inc.’s Chief Development Officer Brannin McBee reported a series of pre-planned insider trades in Class A Common Stock of CRWV. Entities associated with McBee converted a total of 28,000 shares of Class B Common Stock into Class A and sold 28,000 Class A shares in open-market transactions on June 22, 2026.
The transactions were executed indirectly through the Canis Major 2024 Irrevocable Trust LLC, where McBee serves as manager, and the Brannin J. McBee 2022 Irrevocable Trust, for which McBee’s spouse is trustee and spouse and minor child are beneficiaries. A footnote states the sales were carried out under a Rule 10b5-1 trading plan adopted on March 5, 2026, indicating the trades were scheduled in advance rather than timed discretionarily.
Positive
- None.
Negative
- None.
Insights
Pre-planned trust sales and conversions totaling 28,000 shares.
The filing shows entities associated with CoreWeave’s Chief Development Officer converting 28,000 shares of Class B Common Stock into Class A and selling 28,000 Class A shares on June 22, 2026. All transactions are reported as indirect holdings through irrevocable trusts.
Footnotes explain that the Brannin J. McBee 2022 Irrevocable Trust benefits the spouse and minor child, with the spouse as trustee, while McBee manages the Canis Major 2024 Irrevocable Trust LLC. A separate footnote states that the sales occurred under a Rule 10b5-1 trading plan adopted on March 5, 2026, suggesting these trades followed a preset schedule.
From an investor perspective, this pattern resembles a routine convert-and-sell program rather than a sudden discretionary move. The filing does not provide the executive’s total ownership across all forms, so the proportional impact of the 28,000-share net sale on McBee’s overall economic exposure cannot be assessed from this data alone.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Common Stock | 25,000 | $0.00 | -- |
| Conversion | Class B Common Stock | 3,000 | $0.00 | -- |
| Conversion | Class A Common Stock | 25,000 | $0.00 | -- |
| Sale | Class A Common Stock | 1,360 | $107.0529 | $146K |
| Sale | Class A Common Stock | 1,581 | $108.2425 | $171K |
| Sale | Class A Common Stock | 1,969 | $109.2095 | $215K |
| Sale | Class A Common Stock | 4,875 | $110.2747 | $538K |
| Sale | Class A Common Stock | 7,975 | $111.2298 | $887K |
| Sale | Class A Common Stock | 2,689 | $112.0394 | $301K |
| Sale | Class A Common Stock | 1,090 | $112.9699 | $123K |
| Sale | Class A Common Stock | 870 | $114.5012 | $100K |
| Sale | Class A Common Stock | 1,001 | $115.4211 | $116K |
| Sale | Class A Common Stock | 1,180 | $116.4805 | $137K |
| Sale | Class A Common Stock | 200 | $117.421 | $23K |
| Sale | Class A Common Stock | 210 | $119.00 | $25K |
| Conversion | Class A Common Stock | 3,000 | $0.00 | -- |
| Sale | Class A Common Stock | 163 | $107.051 | $17K |
| Sale | Class A Common Stock | 190 | $108.2411 | $21K |
| Sale | Class A Common Stock | 236 | $109.2082 | $26K |
| Sale | Class A Common Stock | 586 | $110.2745 | $65K |
| Sale | Class A Common Stock | 957 | $111.2302 | $106K |
| Sale | Class A Common Stock | 322 | $112.0399 | $36K |
| Sale | Class A Common Stock | 131 | $112.9698 | $15K |
| Sale | Class A Common Stock | 104 | $114.5009 | $12K |
| Sale | Class A Common Stock | 120 | $115.4181 | $14K |
| Sale | Class A Common Stock | 142 | $116.4799 | $17K |
| Sale | Class A Common Stock | 24 | $117.4271 | $3K |
| Sale | Class A Common Stock | 25 | $119.00 | $3K |
Footnotes (1)
- Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. The reported securities are directly held by the Brannin J. McBee 2022 Irrevocable Trust, of which the reporting person's spouse and minor child are beneficiaries and for which the reporting person's spouse serves as trustee. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.63 to $107.62, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.66 to $108.65, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.66 to $109.65, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.66 to $110.65, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.66 to $111.65, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.66 to $112.65, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.67 to $113.58, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.94 to $114.89, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.99 to $115.98, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.00 to $116.99, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.05 to $117.76, inclusive. The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager.